Eugene Starr joins Vascular Pathways as executive president.

Eugene Starr has joined Vascular Pathways, a US-based medical device company backed by Ascension Health Ventures, as executive president.

Until 2006, Starr was executive president of Venetec International, a venture capital-backed manufacturer of the StatLock IV securement device, which was sold to CR Bard for $168m. Before joining Venetec, he was president of Conmed’s Electrosurgery Division, president of Tyco’s Healthcare Group – Canada and spent 17 years at US Surgical.

Vascular is also moving its headquarters from California to…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?